Last updated on September 2018

A Randomized, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of SEP 363856 in Subjects With Parkinson's Disease Psychosis


Brief description of study

A study to evaluate the safety and tolerability of SEP363856 in subjects with Parkinson's Disease Psychosis.

 

Clinical Study Identifier: TX212739

Find a site near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.